It has been suggested that the lack of efficacy of RDN in SYMPLICITY HTN-3 (1) may be due to lack of statistical power, to chance
The primary results of the study failed to show a larger reduction in office BP and ABPM compared with those of sham treatment at 6 months (1) . In this issue of the Journal, the SYMPLICITY HTN-3 investigators report office systolic BP (SBP) and ABPM after 1 year in most of the patients originally randomized to RDN and in patients in the sham group who did and did not undergo RDN after 6 months (2).
In the original RDN patients (n ¼ 319), office SBP was slightly lower at 12 months than at 6 months (À15.5 vs. À18.9 mm Hg, respectively; p < 0.025), but that he has no relationships relevant to the contents of this paper to disclose. Stanley S. Franklin, MD, served as Guest Editor for this paper. 
